Compare BHVN & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | JBLU |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | United States |
| Employees | 274 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2022 | 2002 |
| Metric | BHVN | JBLU |
|---|---|---|
| Price | $8.39 | $4.20 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 14 | 14 |
| Target Price | ★ $28.85 | $4.90 |
| AVG Volume (30 Days) | 1.9M | ★ 25.9M |
| Earning Date | 03-02-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.08 | ★ 27.83 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $9,062,000,000.00 |
| Revenue This Year | N/A | $10.46 |
| Revenue Next Year | N/A | $7.25 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.48 | $3.34 |
| 52 Week High | $26.48 | $6.46 |
| Indicator | BHVN | JBLU |
|---|---|---|
| Relative Strength Index (RSI) | 31.82 | 40.26 |
| Support Level | $8.40 | $4.00 |
| Resistance Level | $11.92 | $4.72 |
| Average True Range (ATR) | 0.59 | 0.26 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 5.51 | 28.13 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.